Article: Citron Research “Exposes” Exact Sciences – Short Term Target $20

Article - Media

Citron Research “Exposes” Exact Sciences – Short Term Target $20

Guest

ValueWalk.com, 15 May 2017

Citron Research exposes Exact Sciences and PROVES beyond ANY doubt why this stock will soon be cut in half  – so says a new reprot from Citron Research – Citron founder Andrew Left  battled the CEO of Exact on CNBC on that topic for CNBC pro sub subscribers you can find that video here

Comment:  Knocked stock down from $30 to $22. They needed to cover, stock then went to $125.